Physician profile
Staci E Biegner
NPI 1669903522
$441.69
in general payments reported to CMS, 2019-2025
14 companies · $66.05 in 2025
The $66.05 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $39.27 · 2022: $122 · 2023: $101 · 2024: $113 · 2025: $66.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $280.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $79.57 | 2021-2025 | Myosure Tissue Removal Device, Acessa Provu System, Novasure |
| Abbvie INC. | $53.78 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $49.60 | 2021-2024 | |
| Sage Therapeutics, LLC | $47.76 | 2024-2025 | Zurzuvae |
| Coopersurgical, INC. | $41.60 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Axonics, INC. | $32.69 | 2022-2023 | Axonics |
| Exact Sciences Corporation | $22.47 | 2023 | Cologuard Collection Kit |
| Ethicon US, LLC | $21.71 | 2022 | |
| Novo Nordisk INC | $20.34 | 2025 | Wegovy |
| Exeltis, USA INC. | $18.26 | 2023 | Slynd |
| Daiichi Sankyo INC. | $14.73 | 2022 | |
| Supernus Pharmaceuticals, INC. | $14.06 | 2025 | Qelbree |
| Sumitomo Pharma America, INC. | $13.94 | 2024 | Myfembree |
| Organon LLC | $11.18 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Staci Biegner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.